Zim Laboratories Ltd

Growth Ratio Summary

Growth Score : 6.00

The company has strong revenue and asset growth. However, the negative earnings per share (EPS) growth and net income growth are concerning. The company's growth trajectory is promising in terms of revenue and assets, but profitability needs to catch up to ensure sustainable expansion.

Financial Ratio Summary

Financial Score : 4.00

Financial ratios indicate areas of concern. Adjusted earnings per share and book value per share are low, while cash earnings per share is somewhat better. The company makes no dividend payments and has significant capital expenditures. It should focus on improving these financial metrics to bolster investor confidence and long-term sustainability.

Profitability Ratio Summary

Profitability Score : 7.20

The company's profitability ratios show strengths and weaknesses. Gross profit margin, return on capital employed (ROCE), return on assets (ROA), and operating margin are robust. Return on equity (ROE) and net margin are low. The company is generating good returns on its capital and assets, but struggles to translate this into net profits and equity returns. Improving net margin and ROE should be a priority.

Efficiency Ratio Summary

Efficiency Score : 4.67

Efficiency ratios reveal mixed performance. While days sales in inventory and receivable days are high, suggesting effective working capital management, the fixed asset and capital turnover ratios are low. The company may not utilize its assets efficiently to generate revenue. While specific to the healthcare industry, addressing asset utilization could unlock further value.

Coverage Ratio Summary

Coverage Score : 5.60

The company's coverage ratios present a mixed picture. The interest coverage ratio is adequate, indicating the company can meet its interest obligations. The absence of dividend payments results in a low equity dividend coverage ratio. The ability to comfortably cover interest expenses is a positive sign, while dividend policies reflect capital allocation decisions.

Solvency Ratio Summary

Solvency Score : 10.00

The company's solvency position appears strong, characterized by a high equity ratio and low debt ratios, indicating a reliance on equity financing rather than debt. While a debt-free status can be seen as a positive, it might also suggest missed opportunities for leveraging debt to fuel growth. The company's financial structure appears conservative, focusing on maintaining a strong equity base.

Liquidity Ratio Summary

Liquidity Score : 2.00

The company's liquidity position is weak, indicating potential difficulties in meeting short-term obligations. The current, quick, and cash ratios are notably low, suggesting limited liquid assets. On a positive note, the company's operating cash flow might provide some support. The healthcare industry's specific working capital needs should be considered, but the low ratios raise concerns about financial flexibility.